Healthcare · Industry
Biotechnology - List & Prices (656 stocks)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| REGENXBIO Inc. | RGNX | $8.94 | $590.16M | — | |
| Cabaletta Bio, Inc. | CABA | $3.47 | $588.32M | — | |
| Eikon Therapeutics, Inc. | EIKN | $10.86 | $588.23M | — | |
| ARS Pharmaceuticals, Inc. | SPRY | $5.62 | $558.89M | — | |
| Eupraxia Pharmaceuticals Inc. | EPRX | $8.40 | $555.02M | — | |
| Artiva Biotherapeutics, Inc. | ARTV | $11.19 | $547.08M | — | |
| Ovid Therapeutics Inc. | OVID | $2.80 | $546.83M | — | |
| Capricor Therapeutics, Inc. | CAPR | $9.40 | $546.51M | — | |
| Scribe Therapeutics Inc. | SCTX | $28.67 | $542.77M | — | |
| Entera Bio Ltd. | ENTX | $3.00 | $519.43M | — | |
| Kyverna Therapeutics, Inc. | KYTX | $8.25 | $510.21M | — | |
| Prothena Corporation plc | PRTA | $9.82 | $504.13M | — | |
| Editas Medicine, Inc. | EDIT | $3.23 | $496.06M | — | |
| Puma Biotechnology, Inc. | PBYI | $9.55 | $492.97M | 18.7 | — |
| Relmada Therapeutics, Inc. | RLMD | $4.43 | $472.55M | — | |
| Vogenx, Inc. | VOGX | $31.73 | $471.35M | — | |
| Ginkgo Bioworks Holdings, Inc. | DNA | $6.95 | $468.01M | — | |
| Atea Pharmaceuticals, Inc. | AVIR | $5.83 | $467.59M | — | |
| Galectin Therapeutics Inc. | GALT | $4.61 | $464.92M | — | |
| C4 Therapeutics, Inc. | CCCC | $3.76 | $462.57M | — | |
| Ocugen, Inc. | OCGN | $1.36 | $461.19M | — | |
| Arcturus Therapeutics Holdings Inc. | ARCT | $15.82 | $449.65M | — | |
| Evommune, Inc. | EVMN | $12.27 | $445.30M | — | |
| Rezolute, Inc. | RZLT | $4.58 | $441.02M | — | |
| Prelude Therapeutics Incorporated | PRLD | $5.46 | $435.73M | — | |
| Benitec Biopharma Inc. | BNTC | $12.68 | $435.61M | — | |
| Fennec Pharmaceuticals Inc. Common Stock | FENC | $12.39 | $434.48M | — | |
| Compass Therapeutics, Inc. | CMPX | $2.38 | $428.61M | — | |
| Rocket Pharmaceuticals, Inc. | RCKT | $3.86 | $423.73M | — | |
| PureTech Health plc | PRTC | $17.38 Jul 17, 2026 | $419.90M | — | |
| Cybin Inc. | CYBN | $6.81 Feb 20, 2026 | $413.12M | — | |
| Enanta Pharmaceuticals, Inc. | ENTA | $14.08 | $410.09M | — | |
| Lexeo Therapeutics, Inc. | LXEO | $4.89 | $401.21M | — | |
| X4 Pharmaceuticals, Inc. | XFOR | $4.04 | $400.55M | 2.8 | — |
| Larimar Therapeutics, Inc. | LRMR | $3.83 | $397.87M | — | |
| Opus Genetics, Inc. | IRD | $4.67 | $388.52M | — | |
| EyePoint, Inc. | EYPT | $4.58 | $383.99M | — | |
| Century Therapeutics, Inc. | IPSC | $2.11 | $382.07M | — | |
| Zentalis Pharmaceuticals, Inc. | ZNTL | $3.99 | $377.74M | — | |
| Agenus Inc. | AGEN | $8.24 | $370.88M | 2.8 | — |
| Palisade Bio, Inc. | PALI | $2.09 | $364.23M | 3.2 | — |
| DiaMedica Therapeutics Inc. | DMAC | $6.75 | $364.00M | — | |
| Q32 Bio Inc. | QTTB | $11.99 | $356.94M | 3.8 | — |
| Lyell Immunopharma, Inc. | LYEL | $14.37 | $352.14M | — | |
| Inhibikase Therapeutics, Inc. | IKT | $2.50 | $348.84M | — | |
| Abeona Therapeutics Inc. | ABEO | $6.00 | $343.10M | — | |
| SAB Biotherapeutics, Inc. | SABS | $3.72 | $338.47M | 15.5 | — |
| Sutro Biopharma, Inc. | STRO | $20.07 | $332.78M | — | |
| Upstream Bio, Inc. | UPB | $6.01 | $329.17M | — | |
| Clinuvel Pharmaceuticals Limited | CUVL | $6.52 | $328.79M | 13.6 | 0.58% |
REGENXBIO Inc.
Healthcare / Biotechnology
- Market Cap
- $590.16M
- P/E
- unprofitable
Cabaletta Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $588.32M
- P/E
- unprofitable
Eikon Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $588.23M
- P/E
- unprofitable
ARS Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $558.89M
- P/E
- unprofitable
Eupraxia Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $555.02M
- P/E
- unprofitable
Artiva Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $547.08M
- P/E
- unprofitable
Ovid Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $546.83M
- P/E
- unprofitable
Capricor Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $546.51M
- P/E
- unprofitable
Scribe Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $542.77M
- P/E
- unprofitable
Entera Bio Ltd.
Healthcare / Biotechnology
- Market Cap
- $519.43M
- P/E
- unprofitable
Kyverna Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $510.21M
- P/E
- unprofitable
Prothena Corporation plc
Healthcare / Biotechnology
- Market Cap
- $504.13M
- P/E
- unprofitable
Editas Medicine, Inc.
Healthcare / Biotechnology
- Market Cap
- $496.06M
- P/E
- unprofitable
Puma Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $492.97M
- P/E
- 18.7
Relmada Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $472.55M
- P/E
- unprofitable
Vogenx, Inc.
Healthcare / Biotechnology
- Market Cap
- $471.35M
- P/E
- unprofitable
Ginkgo Bioworks Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $468.01M
- P/E
- unprofitable
Atea Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $467.59M
- P/E
- unprofitable
Galectin Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $464.92M
- P/E
- unprofitable
C4 Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $462.57M
- P/E
- unprofitable
Ocugen, Inc.
Healthcare / Biotechnology
- Market Cap
- $461.19M
- P/E
- unprofitable
Arcturus Therapeutics Holdings Inc.
Healthcare / Biotechnology
- Market Cap
- $449.65M
- P/E
- unprofitable
Evommune, Inc.
Healthcare / Biotechnology
- Market Cap
- $445.30M
- P/E
- unprofitable
Rezolute, Inc.
Healthcare / Biotechnology
- Market Cap
- $441.02M
- P/E
- unprofitable
Prelude Therapeutics Incorporated
Healthcare / Biotechnology
- Market Cap
- $435.73M
- P/E
- unprofitable
Benitec Biopharma Inc.
Healthcare / Biotechnology
- Market Cap
- $435.61M
- P/E
- unprofitable
Fennec Pharmaceuticals Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $434.48M
- P/E
- unprofitable
Compass Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $428.61M
- P/E
- unprofitable
Rocket Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $423.73M
- P/E
- unprofitable
PureTech Health plc
Healthcare / Biotechnology
- Market Cap
- $419.90M
- P/E
- unprofitable
Cybin Inc.
Healthcare / Biotechnology
- Market Cap
- $413.12M
- P/E
- unprofitable
Enanta Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $410.09M
- P/E
- unprofitable
Lexeo Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $401.21M
- P/E
- unprofitable
X4 Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $400.55M
- P/E
- 2.8
Larimar Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $397.87M
- P/E
- unprofitable
Opus Genetics, Inc.
Healthcare / Biotechnology
- Market Cap
- $388.52M
- P/E
- unprofitable
EyePoint, Inc.
Healthcare / Biotechnology
- Market Cap
- $383.99M
- P/E
- unprofitable
Century Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $382.07M
- P/E
- unprofitable
Zentalis Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $377.74M
- P/E
- unprofitable
Agenus Inc.
Healthcare / Biotechnology
- Market Cap
- $370.88M
- P/E
- 2.8
Palisade Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $364.23M
- P/E
- 3.2
DiaMedica Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $364.00M
- P/E
- unprofitable
Q32 Bio Inc.
Healthcare / Biotechnology
- Market Cap
- $356.94M
- P/E
- 3.8
Lyell Immunopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $352.14M
- P/E
- unprofitable
Inhibikase Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $348.84M
- P/E
- unprofitable
Abeona Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $343.10M
- P/E
- unprofitable
SAB Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $338.47M
- P/E
- 15.5
Sutro Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $332.78M
- P/E
- unprofitable
Upstream Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $329.17M
- P/E
- unprofitable
Clinuvel Pharmaceuticals Limited
Healthcare / Biotechnology
- Market Cap
- $328.79M
- P/E
- 13.6
- Dividend Yield
- 0.58%
Showing 251–300 of 656 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.